DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $511,999 | +3.3% | 2,065 | 0.0% | 0.38% | +1.1% |
| Q2 2023 | $495,600 | -4.8% | 2,065 | 0.0% | 0.37% | 0.0% |
| Q1 2023 | $520,463 | +82251.7% | 2,065 | -13.3% | 0.37% | -22.9% |
| Q4 2022 | $632 | -99.9% | 2,381 | -3.9% | 0.48% | -5.3% |
| Q3 2022 | $640,000 | +1.9% | 2,477 | 0.0% | 0.51% | +9.4% |
| Q2 2022 | $628,000 | -13.6% | 2,477 | 0.0% | 0.47% | +0.6% |
| Q1 2022 | $727,000 | -10.8% | 2,477 | 0.0% | 0.46% | -6.4% |
| Q4 2021 | $815,000 | +2.6% | 2,477 | -5.0% | 0.50% | -9.8% |
| Q3 2021 | $794,000 | +13.4% | 2,607 | 0.0% | 0.55% | +12.0% |
| Q2 2021 | $700,000 | +19.3% | 2,607 | 0.0% | 0.49% | +18.3% |
| Q1 2021 | $587,000 | +4.3% | 2,607 | +2.8% | 0.42% | -13.3% |
| Q4 2020 | $563,000 | -18.0% | 2,535 | -20.6% | 0.48% | -20.1% |
| Q3 2020 | $687,000 | +21.8% | 3,191 | 0.0% | 0.60% | +18.5% |
| Q2 2020 | $564,000 | +27.6% | 3,191 | 0.0% | 0.51% | +17.9% |
| Q1 2020 | $442,000 | -9.8% | 3,191 | 0.0% | 0.43% | +4.6% |
| Q4 2019 | $490,000 | +6.3% | 3,191 | 0.0% | 0.41% | +5.4% |
| Q3 2019 | $461,000 | +1.1% | 3,191 | 0.0% | 0.39% | +4.0% |
| Q2 2019 | $456,000 | +8.3% | 3,191 | 0.0% | 0.38% | +5.9% |
| Q1 2019 | $421,000 | +28.0% | 3,191 | 0.0% | 0.35% | +10.6% |
| Q4 2018 | $329,000 | -7.3% | 3,191 | -2.4% | 0.32% | +14.3% |
| Q3 2018 | $355,000 | +17.5% | 3,271 | +6.9% | 0.28% | +8.1% |
| Q2 2018 | $302,000 | -10.1% | 3,061 | -10.9% | 0.26% | -10.7% |
| Q1 2018 | $336,000 | +5.3% | 3,436 | 0.0% | 0.29% | +13.7% |
| Q4 2017 | $319,000 | +6.0% | 3,436 | -2.0% | 0.26% | +14.9% |
| Q3 2017 | $301,000 | +1.7% | 3,506 | 0.0% | 0.22% | +4.7% |
| Q2 2017 | $296,000 | -14.9% | 3,506 | -13.8% | 0.21% | -20.3% |
| Q1 2017 | $348,000 | -11.2% | 4,065 | -18.8% | 0.27% | -6.7% |
| Q3 2016 | $392,000 | -22.5% | 5,005 | 0.0% | 0.28% | -22.6% |
| Q2 2016 | $506,000 | +0.4% | 5,005 | -5.7% | 0.37% | -7.5% |
| Q1 2016 | $504,000 | +1.0% | 5,308 | -1.1% | 0.40% | +10.2% |
| Q4 2015 | $499,000 | -9.8% | 5,368 | -17.3% | 0.36% | +6.8% |
| Q3 2015 | $553,000 | +29.5% | 6,493 | +30.0% | 0.34% | +76.0% |
| Q2 2015 | $427,000 | +46.2% | 4,993 | +45.0% | 0.19% | +41.2% |
| Q1 2015 | $292,000 | – | 3,443 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |